chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Joint swelling, Mass, Pain in extremity, Peripheral swelling
Clinical narrative: swollen elbow joint you could barely touch; headaches; left arm was swollen; lump on left arm near elbow which is tender; lump on left arm near elbow. which is painful; lump on left arm near elbow; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swollen elbow joint you could barely touch), PERIPHERAL SWELLING (left arm was swollen), TENDERNESS (lump on left arm near elbow which is tender), PAIN IN EXTREMITY (lump on left arm near elbow. which is painful) and MASS (lump on left arm near elbow) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced PERIPHERAL SWELLING (left arm was swollen), TENDERNESS (lump on left arm near elbow which is tender), PAIN IN EXTREMITY (lump on left arm near elbow. which is painful) and MASS (lump on left arm near elbow). On an unknown date, the patient experienced JOINT SWELLING (swollen elbow joint you could barely touch) and HEADACHE (headaches). At the time of the report, JOINT SWELLING (swollen elbow joint you could barely touch), PERIPHERAL SWELLING (left arm was swollen), TENDERNESS (lump on left arm near elbow which is tender), PAIN IN EXTREMITY (lump on left arm near elbow. which is painful), MASS (lump on left arm near elbow) and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Ultrasound scan: inconclusive (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up received on 10-MAY-2021; Reporter details updated. Medical history, lab tests details updated. New events Peripheral swelling, Tenderness, Pain in extremity and Headache added.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Tenderness, Ultrasound scan
Clinical narrative: swollen elbow joint you could barely touch; headaches; left arm was swollen; lump on left arm near elbow which is tender; lump on left arm near elbow. which is painful; lump on left arm near elbow; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swollen elbow joint you could barely touch), PERIPHERAL SWELLING (left arm was swollen), TENDERNESS (lump on left arm near elbow which is tender), PAIN IN EXTREMITY (lump on left arm near elbow. which is painful) and MASS (lump on left arm near elbow) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced PERIPHERAL SWELLING (left arm was swollen), TENDERNESS (lump on left arm near elbow which is tender), PAIN IN EXTREMITY (lump on left arm near elbow. which is painful) and MASS (lump on left arm near elbow). On an unknown date, the patient experienced JOINT SWELLING (swollen elbow joint you could barely touch) and HEADACHE (headaches). At the time of the report, JOINT SWELLING (swollen elbow joint you could barely touch), PERIPHERAL SWELLING (left arm was swollen), TENDERNESS (lump on left arm near elbow which is tender), PAIN IN EXTREMITY (lump on left arm near elbow. which is painful), MASS (lump on left arm near elbow) and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Ultrasound scan: inconclusive (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up received on 10-MAY-2021; Reporter details updated. Medical history, lab tests details updated. New events Peripheral swelling, Tenderness, Pain in extremity and Headache added.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysuria, Malaise, Pollakiuria, Urinary tract infection
Clinical narrative: urinary infection; pain when urinating and very low volume and very frequent; pain when urinating and very low volume and very frequent; pain when urinating and very low volume and very frequent; not feeling well; chills; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (urinary infection), DYSURIA (pain when urinating and very low volume and very frequent), POLLAKIURIA (pain when urinating and very low volume and very frequent), URINE OUTPUT DECREASED (pain when urinating and very low volume and very frequent) and MALAISE (not feeling well) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (urinary infection), DYSURIA (pain when urinating and very low volume and very frequent), POLLAKIURIA (pain when urinating and very low volume and very frequent), URINE OUTPUT DECREASED (pain when urinating and very low volume and very frequent), MALAISE (not feeling well) and CHILLS (chills). The patient was treated with AMOXICILLIN for Urinary infection, at a dose of 500 mg and AZITHROMYCIN (AZO) for Urinary infection, at an unspecified dose and frequency. At the time of the report, URINARY TRACT INFECTION (urinary infection), DYSURIA (pain when urinating and very low volume and very frequent), POLLAKIURIA (pain when urinating and very low volume and very frequent), URINE OUTPUT DECREASED (pain when urinating and very low volume and very frequent), MALAISE (not feeling well) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Patient took Amoxicillin 500mg and Azo as treatment for the events.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Urine output decreased
Clinical narrative: urinary infection; pain when urinating and very low volume and very frequent; pain when urinating and very low volume and very frequent; pain when urinating and very low volume and very frequent; not feeling well; chills; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (urinary infection), DYSURIA (pain when urinating and very low volume and very frequent), POLLAKIURIA (pain when urinating and very low volume and very frequent), URINE OUTPUT DECREASED (pain when urinating and very low volume and very frequent) and MALAISE (not feeling well) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (urinary infection), DYSURIA (pain when urinating and very low volume and very frequent), POLLAKIURIA (pain when urinating and very low volume and very frequent), URINE OUTPUT DECREASED (pain when urinating and very low volume and very frequent), MALAISE (not feeling well) and CHILLS (chills). The patient was treated with AMOXICILLIN for Urinary infection, at a dose of 500 mg and AZITHROMYCIN (AZO) for Urinary infection, at an unspecified dose and frequency. At the time of the report, URINARY TRACT INFECTION (urinary infection), DYSURIA (pain when urinating and very low volume and very frequent), POLLAKIURIA (pain when urinating and very low volume and very frequent), URINE OUTPUT DECREASED (pain when urinating and very low volume and very frequent), MALAISE (not feeling well) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Patient took Amoxicillin 500mg and Azo as treatment for the events.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Vaccination site pain
Clinical narrative: bad headaches/ headaches come and go and are often debilitating; The day the shot stopped hurting, her whole body started to feel different/ strange.; shot hurt when it went in; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (The day the shot stopped hurting, her whole body started to feel different/ strange.), VACCINATION SITE PAIN (shot hurt when it went in) and HEADACHE (bad headaches/ headaches come and go and are often debilitating) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 2C1181162) for COVID-19 vaccination.     The patient's past medical history included Epilepsy. Concomitant products included WARFARIN SODIUM (COUMADIN) for Epilepsy.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced FEELING ABNORMAL (The day the shot stopped hurting, her whole body started to feel different/ strange.) and VACCINATION SITE PAIN (shot hurt when it went in). On 24-Mar-2021, the patient experienced HEADACHE (bad headaches/ headaches come and go and are often debilitating). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (The day the shot stopped hurting, her whole body started to feel different/ strange.), VACCINATION SITE PAIN (shot hurt when it went in) and HEADACHE (bad headaches/ headaches come and go and are often debilitating) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Med Info Agent: Patient stated that she received her 1st dose of the Moderna COVID 19 vaccine on 16FEB2021 and her 2nd dose on 20MAR2021 at Health Department. A week after getting the 2nd dose, she started having headache. She has Epilepsy and takes Coumadin. Her doctor thinks the headache might be due to her Epilepsy, but she does not agree because she has always had Epilepsy. She takes Half a Tylenol every 8 hours to relieve the symptom. The symptom is still ongoing.   1st dose Lot #:: 2C1181162 (Patient unsure, it could be ZC1181162) Exp Date: Left Date Received: 16FEB2021 Arm of injection: Left  2nd Dose Lot #: 011L20A Exp Date: Unknown Date Received: 20MAR2021 Arm of injection: Right Consent for safety to follow-up: Yes   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: non significant followup
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: fever; Chills; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (Chills) and FATIGUE (extreme fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE, PROPRANOLOL, LISINOPRIL, ESOMEPRAZOLE, DIAZEPAM and SERTRALINE for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PYREXIA (fever), CHILLS (Chills) and FATIGUE (extreme fatigue). The patient was treated with IBUPROFEN at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PYREXIA (fever), CHILLS (Chills) and FATIGUE (extreme fatigue) outcome was unknown.            Action taken with mRNA-1273 Moderna vaccine was Not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: late for second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (late for second vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (late for second vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (late for second vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   Reporter did not allow further contact
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash in parts where the body has more heat, like the groin and armpit/ allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in parts where the body has more heat, like the groin and armpit/ allergic reaction) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included Rash.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced RASH (Rash in parts where the body has more heat, like the groin and armpit/ allergic reaction). At the time of the report, RASH (Rash in parts where the body has more heat, like the groin and armpit/ allergic reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The reporter mentioned that he does not think this is due to the vaccine (a similar reaction happened to patient 2 years ago). No concomitant medication reported. No treatment medication were reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm Hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm Hurting). At the time of the report, PAIN IN EXTREMITY (Arm Hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment drugs were reported.   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody, Body temperature, Chills, Hyperhidrosis, Influenza like illness
Clinical narrative: Flu like symptoms; sweating; sore arm, couldn't lift; a fever of 103; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (sweating), PAIN IN EXTREMITY (sore arm, couldn't lift), PYREXIA (a fever of 103) and CHILLS (chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia, Epstein-Barr viremia and Colitis.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (sweating), PAIN IN EXTREMITY (sore arm, couldn't lift), PYREXIA (a fever of 103) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (sweating), PAIN IN EXTREMITY (sore arm, couldn't lift), PYREXIA (a fever of 103) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Antinuclear antibody: inconclusive (Inconclusive) Titre was elevated, elevated antibodies. In April 2021, Body temperature: 103 (High) 103.         Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-094672 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Flu like symptoms; sweating; sore arm, couldn't lift; a fever of 103; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (sweating), PAIN IN EXTREMITY (sore arm, couldn't lift), PYREXIA (a fever of 103) and CHILLS (chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia, Epstein-Barr viremia and Colitis.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (sweating), PAIN IN EXTREMITY (sore arm, couldn't lift), PYREXIA (a fever of 103) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (sweating), PAIN IN EXTREMITY (sore arm, couldn't lift), PYREXIA (a fever of 103) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Antinuclear antibody: inconclusive (Inconclusive) Titre was elevated, elevated antibodies. In April 2021, Body temperature: 103 (High) 103.         Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-094672 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Decreased appetite, Dyspnoea, Fatigue
Clinical narrative: low blood pressure; head is foggy; felt like I had the flu; has no energy and very weak; has not eaten; chest pain; very sick; trouble breathing; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Apr-2021 and was forwarded to Moderna on 28-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (head is foggy), INFLUENZA (felt like I had the flu), ASTHENIA (has no energy and very weak), DECREASED APPETITE (has not eaten) and CHEST PAIN (chest pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Lung cancer stage IV and GERD. Concomitant products included LANSOPRAZOLE (GERD), FOLIC ACID and THYROID for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced FEELING ABNORMAL (head is foggy), INFLUENZA (felt like I had the flu), ASTHENIA (has no energy and very weak), DECREASED APPETITE (has not eaten), CHEST PAIN (chest pain), ILLNESS (very sick), DYSPNOEA (trouble breathing) and FATIGUE (fatigue). On 22-Apr-2021, the patient experienced HYPOTENSION (low blood pressure). At the time of the report, FEELING ABNORMAL (head is foggy), INFLUENZA (felt like I had the flu), ASTHENIA (has no energy and very weak), DECREASED APPETITE (has not eaten), CHEST PAIN (chest pain), ILLNESS (very sick), DYSPNOEA (trouble breathing), FATIGUE (fatigue) and HYPOTENSION (low blood pressure) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included: immunotherapy and chemotherapy every 3 weeks, maintenance medications, high blood pressure medication
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypotension, Illness, Influenza
Clinical narrative: low blood pressure; head is foggy; felt like I had the flu; has no energy and very weak; has not eaten; chest pain; very sick; trouble breathing; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Apr-2021 and was forwarded to Moderna on 28-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (head is foggy), INFLUENZA (felt like I had the flu), ASTHENIA (has no energy and very weak), DECREASED APPETITE (has not eaten) and CHEST PAIN (chest pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Lung cancer stage IV and GERD. Concomitant products included LANSOPRAZOLE (GERD), FOLIC ACID and THYROID for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced FEELING ABNORMAL (head is foggy), INFLUENZA (felt like I had the flu), ASTHENIA (has no energy and very weak), DECREASED APPETITE (has not eaten), CHEST PAIN (chest pain), ILLNESS (very sick), DYSPNOEA (trouble breathing) and FATIGUE (fatigue). On 22-Apr-2021, the patient experienced HYPOTENSION (low blood pressure). At the time of the report, FEELING ABNORMAL (head is foggy), INFLUENZA (felt like I had the flu), ASTHENIA (has no energy and very weak), DECREASED APPETITE (has not eaten), CHEST PAIN (chest pain), ILLNESS (very sick), DYSPNOEA (trouble breathing), FATIGUE (fatigue) and HYPOTENSION (low blood pressure) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included: immunotherapy and chemotherapy every 3 weeks, maintenance medications, high blood pressure medication
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of herpes zoster (shingles) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 040B21A) for COVID-19 immunization. No medical history reported. On Apr 12, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On Apr 16, 2021, patient experienced herpes zoster (shingles). The patient treated with valacyclovir for shingles; 1 dosage form. At the time of the report, herpes zoster (shingles) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or concomitant medications.
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Incorrect product storage; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Incorrect product storage) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Incorrect product storage). At the time of the report, PRODUCT STORAGE ERROR (Incorrect product storage) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. The treatment information was unknown. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Very tired; fever; dizziness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PAIN IN EXTREMITY (Sore arm), PYREXIA (fever) and FATIGUE (Very tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced DIZZINESS (dizziness) and PAIN IN EXTREMITY (Sore arm). On 23-Apr-2021, the patient experienced PYREXIA (fever). On 24-Apr-2021, the patient experienced FATIGUE (Very tired). At the time of the report, DIZZINESS (dizziness), PAIN IN EXTREMITY (Sore arm), PYREXIA (fever) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant details were provided  No treatment details were provided   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Non significant follow up appended
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Neck pain
Clinical narrative: neck ache; workaholic and he feels bad enough to keep him out of work; headache; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck ache), FEELING ABNORMAL (workaholic and he feels bad enough to keep him out of work) and HEADACHE (headache) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced NECK PAIN (neck ache), FEELING ABNORMAL (workaholic and he feels bad enough to keep him out of work) and HEADACHE (headache). At the time of the report, NECK PAIN (neck ache), FEELING ABNORMAL (workaholic and he feels bad enough to keep him out of work) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis
Clinical narrative: Sweating a lot all over; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating a lot all over) and CHILLS (Chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating a lot all over) and CHILLS (Chills). At the time of the report, HYPERHIDROSIS (Sweating a lot all over) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medicines were not reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Could be a potential adverse event; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Could be a potential adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Could be a potential adverse event). At the time of the report, VACCINATION COMPLICATION (Could be a potential adverse event) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Limb discomfort, Pain
Clinical narrative: Lot of pain; Cant raise arm; Didn't sleep all night; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Lot of pain), LIMB DISCOMFORT (Cant raise arm) and INSOMNIA (Didn't sleep all night) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Lot of pain), LIMB DISCOMFORT (Cant raise arm) and INSOMNIA (Didn't sleep all night). At the time of the report, PAIN (Lot of pain), LIMB DISCOMFORT (Cant raise arm) and INSOMNIA (Didn't sleep all night) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided
Sex: U
Vaccine: COVID19
Symptoms: Arthritis, Headache, Lymphadenopathy, Myalgia
Clinical narrative: Arthritis; Swollen glands; Headache; Sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthritis), LYMPHADENOPATHY (Swollen glands), HEADACHE (Headache) and MYALGIA (Sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (Arthritis), LYMPHADENOPATHY (Swollen glands), HEADACHE (Headache) and MYALGIA (Sore arm). At the time of the report, ARTHRITIS (Arthritis), LYMPHADENOPATHY (Swollen glands), HEADACHE (Headache) and MYALGIA (Sore arm) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.  No Concomitant medication were reported.  No treatment medication were reported.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: the patient had his second dose over 3 months later; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the patient had his second dose over 3 months later) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the patient had his second dose over 3 months later). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the patient had his second dose over 3 months later) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Vaccination site pain, Vaccination site rash
Clinical narrative: feel under the weather; chills; tired; rash on right arm at the injection site that is round in circle; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel under the weather), CHILLS (chills), FATIGUE (tired), VACCINATION SITE RASH (rash on right arm at the injection site that is round in circle) and VACCINATION SITE PAIN (sore arm) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and PAROXETINE for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 27-Apr-2021, the patient experienced MALAISE (feel under the weather), CHILLS (chills), FATIGUE (tired) and VACCINATION SITE RASH (rash on right arm at the injection site that is round in circle). At the time of the report, MALAISE (feel under the weather), CHILLS (chills), FATIGUE (tired), VACCINATION SITE RASH (rash on right arm at the injection site that is round in circle) and VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication also include apple cyder vinegar gummies and chlorthalicone.  Treatment details include anti-itch cream.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Influenza like illness, Myalgia, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Negative COVID19 Virus test; Low grade fever; body aches; flu like symptoms; Lost sense of smell;  patient cannnot smell if someone is cutting grass next door; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), ANOSMIA (Lost sense of smell;  patient cannnot smell if someone is cutting grass next door), SARS-COV-2 TEST NEGATIVE (Negative COVID19 Virus test), PYREXIA (Low grade fever) and MYALGIA (body aches) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 045B21A.) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), ANOSMIA (Lost sense of smell;  patient cannnot smell if someone is cutting grass next door), PYREXIA (Low grade fever) and MYALGIA (body aches). On 30-Apr-2021, the patient experienced SARS-COV-2 TEST NEGATIVE (Negative COVID19 Virus test). On 26-Apr-2021, INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (Low grade fever) and MYALGIA (body aches) had resolved. At the time of the report, ANOSMIA (Lost sense of smell;  patient cannnot smell if someone is cutting grass next door) and SARS-COV-2 TEST NEGATIVE (Negative COVID19 Virus test) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: NNI
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: vaccination site told the consumer that he need to wait for 90 days before getting his second dose; got COVID-19 positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (got COVID-19 positive) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccination site told the consumer that he need to wait for 90 days before getting his second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.No concomitant medication was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (got COVID-19 positive). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccination site told the consumer that he need to wait for 90 days before getting his second dose). At the time of the report, SARS-COV-2 TEST POSITIVE (got COVID-19 positive) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccination site told the consumer that he need to wait for 90 days before getting his second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, SARS-CoV-2 test: Positive.   Treatment medication was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Myalgia
Clinical narrative: Numbness in the right side of the body; Soreness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in the right side of the body), MYALGIA (Soreness) and HEADACHE (Headache) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN, LISINOPRIL and INSULIN ASPART (NOVOLOG) for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness in the right side of the body), MYALGIA (Soreness) and HEADACHE (Headache). At the time of the report, HYPOAESTHESIA (Numbness in the right side of the body), MYALGIA (Soreness) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pain in extremity, Rhinorrhoea
Clinical narrative: Runny nose; Feel dizzy; Headache; Tired; Sore injected arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore injected arm), RHINORRHOEA (Runny nose), DIZZINESS (Feel dizzy), HEADACHE (Headache) and FATIGUE (Tired) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ALLEGRA D) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore injected arm). On 25-Apr-2021, the patient experienced RHINORRHOEA (Runny nose), DIZZINESS (Feel dizzy), HEADACHE (Headache) and FATIGUE (Tired). At the time of the report, PAIN IN EXTREMITY (Sore injected arm), RHINORRHOEA (Runny nose), DIZZINESS (Feel dizzy), HEADACHE (Headache) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Impaired work ability, Mobility decreased, Pain in extremity
Clinical narrative: Sore arm; Hard to lift the arm; No energy; Barely can do any normal routine work / errands; Injection site is very sore; Very drained; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MOBILITY DECREASED (Hard to lift the arm), ASTHENIA (No energy), IMPAIRED WORK ABILITY (Barely can do any normal routine work / errands) and VACCINATION SITE PAIN (Injection site is very sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), MOBILITY DECREASED (Hard to lift the arm), ASTHENIA (No energy), IMPAIRED WORK ABILITY (Barely can do any normal routine work / errands), VACCINATION SITE PAIN (Injection site is very sore) and FATIGUE (Very drained). At the time of the report, PAIN IN EXTREMITY (Sore arm), MOBILITY DECREASED (Hard to lift the arm), ASTHENIA (No energy), IMPAIRED WORK ABILITY (Barely can do any normal routine work / errands), VACCINATION SITE PAIN (Injection site is very sore) and FATIGUE (Very drained) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm; Hard to lift the arm; No energy; Barely can do any normal routine work / errands; Injection site is very sore; Very drained; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MOBILITY DECREASED (Hard to lift the arm), ASTHENIA (No energy), IMPAIRED WORK ABILITY (Barely can do any normal routine work / errands) and VACCINATION SITE PAIN (Injection site is very sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), MOBILITY DECREASED (Hard to lift the arm), ASTHENIA (No energy), IMPAIRED WORK ABILITY (Barely can do any normal routine work / errands), VACCINATION SITE PAIN (Injection site is very sore) and FATIGUE (Very drained). At the time of the report, PAIN IN EXTREMITY (Sore arm), MOBILITY DECREASED (Hard to lift the arm), ASTHENIA (No energy), IMPAIRED WORK ABILITY (Barely can do any normal routine work / errands), VACCINATION SITE PAIN (Injection site is very sore) and FATIGUE (Very drained) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: aches in both shoulders, left wrist and right knee; JOINT PAIN PERSISTING; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (aches in both shoulders, left wrist and right knee) and ARTHRALGIA (JOINT PAIN PERSISTING) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 031B21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, AMLODIPINE, LISINOPRIL, DABIGATRAN ETEXILATE MESILATE (PRADAXA) and PRAZOSIN for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced ARTHRALGIA (aches in both shoulders, left wrist and right knee). 12-Mar-2021, the patient experienced ARTHRALGIA (JOINT PAIN PERSISTING). At the time of the report, ARTHRALGIA (aches in both shoulders, left wrist and right knee) and ARTHRALGIA (JOINT PAIN PERSISTING) outcome was unknown. Not Provided          TREATMENT MEDICATION TYLENOL WAS USED
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Product dose omission issue
Clinical narrative: Sick after 1st dose; Did not get the 2nd dose within day 25-35; This spontaneous case was reported by a physician and describes the occurrence of ILLNESS (Sick after 1st dose) and PRODUCT DOSE OMISSION ISSUE (Did not get the 2nd dose within day 25-35) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick after 1st dose) and PRODUCT DOSE OMISSION ISSUE (Did not get the 2nd dose within day 25-35). At the time of the report, ILLNESS (Sick after 1st dose) and PRODUCT DOSE OMISSION ISSUE (Did not get the 2nd dose within day 25-35) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No treatment information was reported.